AlphaFold: Five years of impact

Source: DeepMind Date: 2025-11-25 URL: https://deepmind.google/blog/alphafold-five-years-of-impact/

Summary

Five-year retrospective on AlphaFold 2: 3 million researchers across 190+ countries, 1 million from low/middle-income countries, 35,000+ direct citations, 200,000+ papers incorporating the methodology. Research linked to AlphaFold is 2x as likely to appear in clinical articles and significantly more likely in patent citations. 40% increase in novel experimental protein structure submissions. AlphaFold 3 expanded to DNA/RNA/ligand interactions, enabling “digital biology” approaches to drug discovery.

Implications

3 million researchers is the installed base that no other AI science tool approaches. AlphaFold adoption at this scale means structural biology workflows globally have been reorganized around AI prediction rather than experimental determination alone. The comparison to any other AI science tool (AlphaGenome, AI Co-scientist) starts from this baseline — AlphaFold is 5 years ahead.

Clinical citation signal is the economic claim. 2x more likely to appear in clinical research articles means AlphaFold outputs are informing drug development decisions, not just basic science. Patent citations further confirm commercial R&D application. That’s the vector by which DeepMind’s science work translates into economic value for Google.

AlphaFold 3’s molecular scope expansion changes the playbook. Going from protein structure to DNA/RNA/ligand interactions is a platform expansion from structural biology to computational drug discovery. The “digital biology” framing positions AlphaFold 3 as enabling a complete in-silico drug pipeline — design, screen, predict — before a single wet-lab experiment.

Watch:

• AlphaFold 3 adoption trajectory relative to AF2’s 5-year curve — does the expanded scope accelerate or slow adoption?
• Drug discovery partnerships that publicly attribute AF3 to specific compound advancement
• LMIC usage at 1M researchers — is that growing or stable? Access expansion in the Global South is both a values claim and a strategic market development